Clinical Trial Update: Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating cryoablation in combination with sintilimab and regorafenib for previously treated colorectal cancer with liver meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Regorafenib (regorafenib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Liver Metastases, Colorectal Cancer Metastatic | Phase 2 | Status: RECRUITING